Measurement of Renal Function With Iohexol in Subjects Ingesting Carnitine
NCT01392313 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2018-07-23
Summary
The investigators will measure renal function in subjects ingesting carnitine to determine if the product alters renal function.
Conditions
- Carnitine Ingestion
Interventions
- DIETARY_SUPPLEMENT
-
Carnitine
Carnitine Ingestion
- DIETARY_SUPPLEMENT
-
Placebo
Carnitine placebo
Sponsors & Collaborators
-
Montefiore Medical Center
lead OTHER
Principal Investigators
-
Joel Neugarten, MD · Montefiore Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-05-31
- Primary Completion
- 2010-06-30
- Completion
- 2010-06-30
Countries
- United States
Study Locations
More Related Trials
-
A Study to Look at How a Single Oral Dose of Carbon-14-Labelled [14C] BIIB091 Moves Through and is Processed by the Body in Healthy Male Participants
NCT06311786 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetics Study of Radioactive-Labeled GDC-0973 in Healthy Male Volunteers
NCT01711762 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Investigating [14C]-Labeled RO7269162 in Healthy Male Participants
NCT06733298 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Study of CXB909 in Healthy Male Subjects
NCT01505907 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study of The Excretion Balance, Pharmacokinetics and Metabolism of A Single Oral Dose of [14C]-Labeled RO4917523 in Healthy Male Volunteers
NCT01592890 ·Status: COMPLETED ·Phase: PHASE1
-
Dose-Finding of Retinoid 9cUAB30 in Healthy Volunteers
NCT01336387 ·Status: TERMINATED ·Phase: PHASE1
-
A Study of the Excretion Balance of Radiocarbon and the Pharmacokinetics and Metabolic Profile of TRO19622 (Olesoxime)
NCT02835976 ·Status: COMPLETED ·Phase: PHASE1
-
Investigating Project of the Functional C13 Test "Pilot Study"
NCT01560897 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study of the Pharmacokinetics of Three Dosages of Niagen in Healthy Subjects
NCT02191462 ·Status: COMPLETED ·Phase: PHASE1
-
Single-Dose, Open-Label Pharmacokinetic Study of Bardoxolone Methyl in Subjects With Mild, Moderate, and Severe Hepatic Impairment and Normal Hepatic Function
NCT01563562 ·Status: COMPLETED ·Phase: PHASE1
-
Absorption, Metabolism and Excretion (AME) of Single Dose Radiolabeled BVD-523 in Volunteers
NCT02994732 ·Status: COMPLETED ·Phase: PHASE1
-
Kinetics of Yohimbine in Humans to Explore Sex and CYP2D6 Genotype Interactions
NCT06939608 ·Status: COMPLETED ·Phase: NA
-
A Study of How [14C]-BGB-16673 is Absorbed, Broken Down, and Removed From the Body After a Single Oral Dose in Healthy Participants
NCT06776679 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Study to Investigate the Absorption, Metabolism and Excretion in Healthy Male Subjects
NCT01503866 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of MP-3180 in Healthy Volunteers
NCT02098174 ·Status: COMPLETED ·Phase: PHASE1
-
Metabolism and Pharmacokinetics of [14C]-BI 409306 After Administration as Oral Solution in Healthy Male Volunteers
NCT02597998 ·Status: COMPLETED ·Phase: PHASE1
-
Metabolism and Excretion of [14C]CC-90001 in Healthy Male Subjects
NCT04655898 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate the Pharmacokinetics, Safety, and Tolerability of BMT101 in Healthy Male Volunteers
NCT03133130 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability,Pharmacokinetics and Pharmacodynamics of ODM-106 in Healthy Volunteers
NCT02393950 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetic Study of Omaveloxolone in Subjects With Hepatic Impairment and Normal Hepatic Function
NCT03902002 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of RBT-1 in Healthy Volunteers and Subjects With Stage 3/4 Chronic Kidney Disease
NCT03893799 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety and Pharmacokinetic Study of AG-881 in Healthy Male Participants Following Administration of a Single Oral Dose of [14C] AG-881 and Concomitant Intravenous Microdose of [13C315N3] AG-881
NCT03960502 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Blood Levels of Palovarotene in Participants With Abnormal Liver Function Compared to Healthy Adult Participants After Intake of a Single Dose
NCT06908954 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Drug Levels of [14C]CC-99677 in Healthy Male Participants
NCT05284890 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1 Study in Healthy Participants and Participants With Kidney Dysfunction
NCT06383897 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1